World's Best Scientists 2026 revealed!
Massimo Galli

Massimo Galli

D-Index & Metrics

Immunology

D-Index
82
Citations
28565
World Ranking
1491
National Ranking
59

Medicine

D-Index
83
Citations
29010
World Ranking
15492
National Ranking
600

Overview

Massimo Galli is affiliated with the University of Milan in Italy and has contributed extensively to the field of medicine, with a particular focus on infectious diseases. Their scholarly output includes a significant number of publications emphasizing clinical and epidemiological aspects of COVID-19 and related viral infections.

Their main fields of study comprise Medicine, with a specific concentration in Infectious Diseases. Additional subfields of their research include Epidemiology, Neurology, Genetics, and Radiology, Nuclear Medicine and Imaging.

Research topics covered by Massimo Galli reflect a focus on various dimensions of the COVID-19 pandemic, such as:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • COVID-19 epidemiological studies
  • SARS-CoV-2 detection and testing
  • COVID-19 diagnosis using AI
  • COVID-19 and healthcare impacts

Among the most cited recent papers associated with Massimo Galli are:

  • "Remdesivir for 5 or 10 Days in Patients with Severe Covid-19" (2020), published in the New England Journal of Medicine
  • "Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study" (2020), published in The Lancet Infectious Diseases
  • "Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study" (2020), published in Clinical Infectious Diseases
  • "Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity" (2021), published in Cell
  • "Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms" (2020), published in Science

Massimo Galli has collaborated frequently with other researchers, including:

  • Andrea Giacomelli
  • Spinello Antinori
  • Alessia Lai
  • Gianguglielmo Zehender
  • Stefano Rusconi

They have published extensively in several key venues, notably:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccines
  • Clinical and Experimental Rheumatology
  • Digestive and Liver Disease
  • Journal of Medical Virology

Best Publications

  • Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.

    Jason D. Goldman;David C.B. Lye;David S. Hui;Kristen M. Marks

  • Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.

    Andrea Giacomelli;Laura Pezzati;Federico Conti;Dario Bernacchia

  • Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.

    Luca Carsana;Aurelio Sonzogni;Ahmed Nasr;Roberta Simona Rossi

  • Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC

    Alessia Lai;Francesco Roberto Simonetti;Gaetano Brindicci;Annalisa Bergna

  • Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.

    Emma C. Thomson;Emma C. Thomson;Laura E. Rosen;James G. Shepherd;Roberto Spreafico

  • Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

    M. Alejandra Tortorici;M. Alejandra Tortorici;Martina Beltramello;Florian A. Lempp;Dora Pinto

  • COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

    Piercarlo Sarzi-Puttini;Valeria Giorgi;Silvia Sirotti;Daniela Marotto

  • A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.

    S De Vita;L Quartuccio;M Isola;C Mazzaro

  • Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection.

    Laura Montefusco;Moufida Ben Nasr;Moufida Ben Nasr;Francesca D'Addio;Cristian Loretelli

  • Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy

    Cristina Gervasoni;Anna Lisa Ridolfo;Giuliana Trifirò;Sara Santambrogio

  • Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias.

    G Monti;M Galli;F Invernizzi;P Pioltelli

  • Candidemia and invasive candidiasis in adults: A narrative review

    Spinello Antinori;Laura Milazzo;Salvatore Sollima;Massimo Galli

  • A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis

    Katie Bechman;Sujith Subesinghe;Sam Norton;Fabiola Atzeni

  • EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2.

    Robert Bm Landewé;Pedro M Machado;Féline Kroon;Hans Wj Bijlsma

  • Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study.

    Sebastiano Bruno Solerte;Francesca D’Addio;Roberto Trevisan;Elisabetta Lovati

  • 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study.

    Andrea Giacomelli;Anna Lisa Ridolfo;Laura Milazzo;Letizia Oreni

  • Retinal findings in patients with COVID-19: Results from the SERPICO-19 study.

    Alessandro Invernizzi;Alessandro Invernizzi;Alessandro Torre;Salvatore Parrulli;Federico Zicarelli

  • Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.

    Maurizio Pietrogrande;Salvatore De Vita;Anna Linda Zignego;Pietro Pioltelli

  • Risk of Kaposi's Sarcoma-Associated Herpes Virus Transmission From Donor Allografts Among Italian Posttransplant Kaposi's Sarcoma Patients

    Carlo Parravicini;Sonja J. Olsen;Maria Capra;Francesca Poli

  • Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.

    Spinello Antinori;Maria Vittoria Cossu;Anna Lisa Ridolfo;Roberto Rech

  • Incidence and Characteristics of Non-Hodgkin Lymphomas in a Multicenter Case File of Patients With Hepatitis C Virus-Related Symptomatic Mixed Cryoglobulinemias

    Giuseppe Monti;Pietro Pioltelli;Francesco Saccardo;Mauro Campanini

  • Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count.

    Giulia Marchetti;Alessandro Cozzi-Lepri;Esther Merlini;Giusi M. Bellistrì

  • Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.

    François-Xavier Lescure;Hitoshi Honda;Robert A Fowler;Jennifer Sloane Lazar

  • Early phylogenetic estimate of the effective reproduction number of SARS-CoV-2.

    Alessia Lai;Annalisa Bergna;Carla Acciarri;Massimo Galli

Frequent Co-Authors

Spinello Antinori
Spinello Antinori University of Milan
Mauro Moroni
Mauro Moroni University of Milan
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University
Claudia Balotta
Claudia Balotta University of Milan
Giuliano Rizzardini
Giuliano Rizzardini ASST Fatebenefratelli Sacco
Andrea Gori
Andrea Gori University of Milan
Cristina Mussini
Cristina Mussini University of Modena and Reggio Emilia
Mario Clerici
Mario Clerici University of Milan
Massimo Ciccozzi
Massimo Ciccozzi Università Campus Bio-Medico
Massimo Andreoni
Massimo Andreoni University of Rome Tor Vergata

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, understanding related healthcare degrees can open new career avenues. Many professionals transition into nursing through specialized programs designed to accelerate their education. For example, online ABSN programs for non nurses provide a streamlined path for individuals without a nursing background to earn a Bachelor of Science in Nursing quickly.

Similarly, there are accelerated BSN programs for non nurses that cater specifically to students eager to fast-track their nursing qualifications. These programs are often more flexible, balancing theoretical coursework with clinical experience.

For entry-level positions, exploring easy LPN programs to get into can be a practical start. Licensed Practical Nurse programs offer essential skills and certification with shorter durations, making them accessible for many.

Advancing clinical expertise is possible through nurse practitioner studies. Those curious about less demanding yet effective options often seek out what is the easiest NP program, helping them identify programs that best fit their learning style and career goals.

Best Scientists Citing Massimo Galli

Trending Scientists

Recently Published Articles